Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-7 of 7
Keywords: compound 21
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Raquel González-Blázquez, Martín Alcalá, José Miguel Cárdenas-Rebollo, Marta Viana, Ulrike Muscha Steckelings, William A. Boisvert, Thomas Unger, María S. Fernández-Alfonso, Beatriz Somoza, Marta Gil-Ortega
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (24): 2763–2780.
Published: 17 December 2021
...Raquel González-Blázquez; Martín Alcalá; José Miguel Cárdenas-Rebollo; Marta Viana; Ulrike Muscha Steckelings; William A. Boisvert; Thomas Unger; María S. Fernández-Alfonso; Beatriz Somoza; Marta Gil-Ortega The aim of the present study was to evaluate the effect of Compound 21 (C21), a selective...
Includes: Supplementary data
Articles
Raquel González-Blázquez, Martín Alcalá, María S. Fernández-Alfonso, Ulrike Muscha Steckelings, M. Paz Lorenzo, Marta Viana, William A. Boisvert, Thomas Unger, Marta Gil-Ortega, Beatriz Somoza
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (9): 1145–1163.
Published: 11 May 2021
...Raquel González-Blázquez; Martín Alcalá; María S. Fernández-Alfonso; Ulrike Muscha Steckelings; M. Paz Lorenzo; Marta Viana; William A. Boisvert; Thomas Unger; Marta Gil-Ortega; Beatriz Somoza Compound 21 (C21), a selective agonist of angiotensin II type 2 receptor (AT 2 R), induces vasodilation...
Includes: Supplementary data
Articles
Paul-Emmanuel Vanderriele, Brasilina Caroccia, Teresa Maria Seccia, Maria Piazza, Livia Lenzini, Francesca Torresan, Maurizio Iacobone, Thomas Unger, Gian Paolo Rossi
Journal:
Clinical Science
Clin Sci (Lond) (2018) 132 (6): 627–640.
Published: 20 March 2018
..., and in APA-adjacent tissue. The effect of Compound 21 (C21), an AT2R agonist, on CYP11B1 (cortisol synthase) and CYP11B2 (aldosterone synthase) gene expression in NCI-H295R and HAC15 cell lines, and in APA and APA-adjacent tissue, was also assessed using the AT1R antagonist irbesartan to ascertain...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (15): 1307–1326.
Published: 29 June 2016
... 6 5 2016 AT2 receptor AT2R agonism cardiovascular compound 21 kidney The biological actions of the renin–angiotensin system (RAS) are regarded to be primarily mediated by the octapeptide, angiotensin II (Ang II). Originally thought to be a circulating endocrine hormone that acts...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2015) 129 (1): 81–92.
Published: 15 April 2015
... pressure responses to stimulation of central AT 2 Rs by the selective agonist Compound 21 in conscious spontaneously hypertensive rats (SHRs) and normotensive Wistar Kyoto rats (WKY rats). We also assessed the impact on noradrenaline [norepinephrine (NE)] plasma levels, autonomic function, spontaneous...
Includes: Supplementary data
Articles
Yi Zhao, Ulf Lützen, Jürgen Fritsch, Maaz Zuhayra, Stefan Schütze, Ulrike M. Steckelings, Chiara Recanti, Pawel Namsoleck, Thomas Unger, Juraj Culman
Journal:
Clinical Science
Clin Sci (Lond) (2015) 128 (9): 567–578.
Published: 11 February 2015
... II and the AT 1 receptor antagonist, losartan, induces apoptosis but does not affect the rate of cell death. We demonstrate for the first time that the high-affinity, non-peptide AT 2 receptor agonist, Compound 21 (C21), penetrates the cell membrane of quiescent SK-UT-1 cells, activates intracellular...
Articles
Sanja Bosnyak, Emma S. Jones, Arthur Christopoulos, Marie-Isabel Aguilar, Walter G. Thomas, Robert E. Widdop
Journal:
Clinical Science
Clin Sci (Lond) (2011) 121 (7): 297–303.
Published: 07 June 2011
... of binding affinities of all the major angiotensin peptides. Additionally, we tested the novel AT 2 R agonist Compound 21, as well as the Mas R ( Mas receptor) agonist and antagonist AVE0991 and A-779 respectively, for their ability to bind to AT 1 R or AT 2 R. Candesartan, CGP42214 and PD123319 were used...